Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-1 antitrypsin for chronic fatigue syndrome (pilot crossover trial)
2014-002007-13Phase 2Terminated
- Sponsor
- Grifols
- Start
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of alpha-1-proteinase inhibitor in myalgic encephalomyelitis (ME) (2 arms), sponsored by Grifols. Primary endpoint: Change in elastase activity in peripheral blood mononuclear cells. Started Jul 2015; status: terminated.
02
Drugs
alpha-1-proteinase inhibitor
03
Conditions
myalgic encephalomyelitis (ME)
Beyond the preview
Go deeper on 2014-002007-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002007-13.